Flucloxacillin

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

OsteomyelitisSkin InfectionCellulitis

64 competitors in Osteomyelitis

#DrugCompanyPhaseTrials

1

Acanya

Pfizer

Approved

—2

Cipro

Bayer

Approved

—3

Priftin

Sanofi

Approved

—4

Zyvox

Pfizer

Approved

—5

Maxipime

Pfizer

Approved

—6

Biaxin

AbbVie

Approved

—7

Avelox

Bayer

Approved

—8

Mycobutin

Pfizer

Approved

—9

Garamycin

SSchering-Plough

Approved

—10

Invanz

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Approved

—Show 40 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Cellulitis3 trials

Duration of ANtibiotic Therapy for CEllulitis

Terminated·—·Phase 4·NCT02032654·151 enrolled

Adjunctive Clindamycin for Cellulitis: C4C Trial.

Completed·UUniversity Hospitals Bristol and Weston NHS Foundation Trust·Phase 4·NCT01876628·410 enrolled

Penicillin for the Emergency Department Outpatient Treatment of CELLulitis

Unknown status·RRoyal College of Surgeons, Ireland·Phase 4·NCT02922686·414 enrolled

Staphylococcus Aureus Bacteremia1 trial

Staphylococcus Aureus Bacteremia Antibiotic Treatment Options

Completed·HHeinrich-Heine University, Duesseldorf·Phase 3·NCT01792804·215 enrolled

Peritoneal Dialysis1 trial

The Effect of Antimicrobial Therapy on the Serum Level of P-cresol in Peritoneal Dialysis Patients

Terminated·UUniversitaire Ziekenhuizen KU Leuven·Phase 1·NCT00433342·9 enrolled

Osteomyelitis1 trial

Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci

Completed·Merck & Co.·Phase 2·NCT00428844·75 enrolled

Infections1 trial

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

Completed·AbbVie·Phase 3·NCT02814916·199 enrolled

5 more indications

Treatment1 trial

Penicillin Against Flucloxacillin Treatment Evaluation

Withdrawn·TThe University of Queensland·Phase 4·NCT03632642

Infusion1 trial

Pharmacokinetics of Flucloxacillin Given by Continuous or Intermittent Infusion to ICU Patients

Completed·RRadboud University Medical Center··NCT02993575·30 enrolled

Skin Infection1 trial

Comparing the Intravenous Treatment of Skin Infections in Children, Home Versus Hospital

Completed·MMurdoch Childrens Research Institute·N/A·NCT02334124·190 enrolled

Breastfeeding1 trial

Study of Acupuncture and Care Interventions for the Treatment of Breast Inflammation During Breastfeeding

Completed·KKarlstad University·N/A·NCT00405158·210 enrolled

Unspecified2 trials

Bioavailability Of Flucloxacillin Capsules (250 mg and 500 mg)

Completed·GSK·Phase 1·NCT00358371·24 enrolled

Flucloxacillin as an Inducer of CYP-enzymes

Completed·UUniversity of Southern Denmark·Phase 1·NCT04840641·14 enrolled

Details

Drug Info

Related News